JCS Lung & Sleep Centre : A7 Madhuban (Preet Vihar) Vikas Marg New Delhi - 110 092

Lung Cancer

Lung Cancer: Symptoms, Types & Treatments

Understanding Lung Cancer

Lung cancer, a devastating disease impacting countless individuals worldwide, demands immediate attention and treatment. This article delves into the topic of lung cancer, exploring its causes, symptoms, diagnosis, and treatment options. By gaining a deeper understanding of this condition, individuals and their loved ones can make informed decisions about their health.

Exploring Lung Cancer Types and Symptoms

Lung cancer manifests through uncontrollable cell growth within the lungs and comprises two primary types: small-cell lung cancer and non-small-cell lung cancer. Further categorized into subtypes such as adenocarcinoma and squamous cell carcinoma, each type exhibits distinct growth patterns requiring specific treatment approaches.

The symptoms of lung cancer can vary, with some individuals experiencing respiratory-related issues, while others present symptoms connected to the spread of cancer to other body parts. Notably, many lung cancer cases remain asymptomatic until reaching an advanced stage.

Lung Cancer Treatment

Common symptoms include:

  • Persistent or Worsening Cough
  • Chest Pain
  • Shortness of Breath
  • Wheezing
  • Coughing up Blood
  • Chronic Fatigue
  • Unexplained Weight Loss


Additionally, lung cancer can cause other changes in the body, such as recurring pneumonia or the enlargement of lymph nodes in the chest area.

Other types of cancer in the lungs

Lung cancer can manifest in various types beyond the common lung cancer, including lymphomas (cancer in lymph nodes), sarcomas (cancer in bones or soft tissue), and pleural mesothelioma (cancer in the lining of the lungs). These types are treated differently and are not typically referred to as lung cancer.

The staging of lung cancer is based on factors like the size of the primary tumor, its extent into surrounding tissues, and whether it has spread to lymph nodes or other organs. Each type of cancer has its own staging guidelines.

For lung cancer, the general staging is as follows:

Stage 0 (in-situ): Cancer is present in the top lining of the lung or bronchus, without spreading to other lung parts or outside the lung itself.

Stage I: Cancer has not spread outside the lung.

Stage II: Cancer is larger than Stage I, has spread to nearby lymph nodes within the lung, or multiple tumors are present in the same lung lobe.

Stage III: Cancer is larger than Stage II, has spread to nearby lymph nodes or adjacent structures, or multiple tumors are found in a different lobe of the same lung.

Stage IV: Cancer has spread to the other lung, the fluid surrounding the lung, the fluid around the heart, or distant organs.

For small cell lung cancer (SCLC), it can be categorized as limited or extensive stage:

Limited stage SCLC is confined to one lung and may involve lymph nodes in the middle of the chest or above the collarbone on the same side.

Extensive stage SCLC has spread widely throughout one lung or to the other lung, lymph nodes on the opposite side of the lung, or other parts of the body.

These stages and classifications help medical professionals determine the appropriate treatment and prognosis for individuals with lung cancer.

Lung Cancer Treatment & Diagnosis

Facing suspected lung cancer necessitates a thorough diagnostic process to determine its stage and type. This process involves imaging tests, biopsies, and genetic mutation analysis.

Staging the cancer is vital for designing an appropriate treatment plan. Healthcare professionals tailor treatments to meet the unique needs of each individual by determining the extent of cancer's spread. Common treatment options for lung cancer include:

  • Surgery: Surgical removal of cancerous tissue.
  • Chemotherapy: Use of powerful drugs to destroy or shrink cancer cells.
  • Radiation Therapy: Application of high-energy rays to eliminate cancer cells.
  • Targeted Therapy: Use of specific drugs to inhibit the growth and spread of cancer cells.

Often, a multidisciplinary approach involving pulmonologists, surgeons, medical oncologists, and radiation oncologists is adopted to deliver the most effective treatment for each patient's condition.

Lung Cancer Treatment

Clinical Trials and Complementary Medicine

Clinical trials play a crucial role in advancing lung cancer treatment options, evaluating the safety and efficacy of new therapies. Individuals diagnosed with lung cancer are encouraged to explore participation in clinical trials to access potentially groundbreaking treatments.

Complementary and alternative medicine practices may also be considered alongside standard treatments. Complementary medicine includes practices like acupuncture, dietary supplements, massage therapy, hypnosis, and meditation, used in conjunction with conventional treatments. 

Alternative medicine, on the other hand, involves non-traditional therapies replacing standard treatments, such as special diets, high-dose vitamins, herbal preparations, and magnet therapy. It is essential to consult with a healthcare professional before adopting any complementary or alternative medicine practices to assess their safety and potential benefits.

Choosing the Right Lung Cancer Treatment

Selecting the appropriate lung cancer treatment can be challenging. A specialized cancer doctor should be consulted, providing in-depth information about available treatment options based on the type and stage of cancer. These medical professionals can guide patients through the potential risks, benefits, and side effects associated with each treatment method. Seeking a second opinion from another reputable oncologist is also a viable option that can provide further clarity and peace of mind.

In Conclusion

Lung cancer is a complex disease demanding comprehensive understanding and proactive management. By familiarizing themselves with the causes, symptoms, diagnosis, and treatment options, individuals affected by lung cancer can take charge of their health journey. Early detection and timely intervention significantly improve the chances of successful treatment and long-term survival.

Lung Cancer

What is Lung Cancer ?

Lung Cancer (LC) may be a sort of cancer that starts within the lungs. Cancer starts when cells within the body begin to grow out of control.

Cancer cells develop because of multiple changes in their genes. These changes can have many possible causes.

Lifestyle habits, genes you get from your parents, and being exposed to cancer-causing agents in the environment can all play a role. Many times, there is no obvious cause.

Certain genes control a cell’s life cycle – growth, function, division, and death. When these genes are damaged, the balance between normal cell growth and death is lost.

Cancer cells are caused by DNA damage and out-of-control cell growth.

What is Lung Cancer


SMOKING- Tobacco usage is by far the most common cause of LC. Around 80% of lung cancer fatalities are caused by smoking, and many more are caused by secondhand smoke exposure.

Although smoking is by far the most significant risk factor for LC, it frequently interacts with other factors.

Smokers are at a significantly greater risk, as are those who are exposed to other known risk factors like radon and asbestos. Because not everyone who smokes develops lung cancer, other factors such as genetics are likely to play a role.

CAUSES IN PEOPLE WHO DON’T SMOKE Lung cancer does not affect everyone who smokes. Many patients with lung cancer have smoked in the past, while many others have never smoked.

Small cell lung cancer (SCLC) can be diagnosed in people who have never smoked, but it does happen.

Exposure to radon, secondhand smoking, pollution, and other factors can cause carcinoma in nonsmokers.

Some persons who don’t smoke can develop carcinoma after being exposed to asbestos, diesel exhaust, or other pollutants at work.

A small percentage of lung cancers arise in patients who have no known risk factors. Some of them could just be random events with no external source, while others could be the result of unknown influences.

Lung cancers in nonsmokers are frequently distinct from those that occur in smokers. They grow in younger persons and frequently have gene modifications that differ from those observed in cancers detected in smokers.

These gene variations can be utilized to guide treatment in some circumstances.

GENES CHANGES THAT MAY LEAD TO LUNG CANCER- Scientists have figured out how some lung cancer risk factors can cause DNA mutations in lung cells.

These modifications may result in aberrant cell development and, in some cases, cancer. Our genes, which determine how our cells work, are made from DNA, a cloth found in our cells. Our DNA, which comes from both parents, has an impact on more than simply our appearance.

It can also increase our chances of contracting certain diseases, such as cancer.

Some genes play a role in determining when cells divide, grow, and die:

Oncogenes are genes that help cells grow, proliferate, or survive.

Tumor suppressor genes help control cell division or induce cells to die at the appropriate moment.

DNA alterations that turn on oncogenes or turn off tumor suppressor genes can cause cancer. Lung cancer is frequently caused by changes in many distinct genes.


There are 2 main sorts of lung cancer:

NSCLC accounts for about 80% to 85% of lung cancer cases. Adenocarcinoma, squamous cell carcinoma, and giant cell carcinoma are the three primary subtypes of NSCLC.

Because their therapy and prognoses (outlook) are typically similar, these subtypes, which start from distinct types of lung cells, are classed together as NSCLC.

Adenocarcinoma: Adenocarcinomas begin in cells that ordinarily release mucus or other substances. This type of carcinoma is commonest in those that smoke or have smoked within the past, but it’s also the foremost common sort of carcinoma detected in nonsmokers.

It affects more women than males, and it’s more common in younger individuals than other sorts of carcinoma.
Adenocarcinoma is most commonly detected in the lungs’ outer layers, and it is more likely to be discovered before it has spread.

People with adenocarcinoma in situ (formerly called bronchioloalveolar carcinoma), a kind of adenocarcinoma, have a better prognosis than those with other types of lung cancer.

Squamous cell carcinomas begin in squamous cells, which are flat cells that line the liner of the lungs’ airways. They are usually seen within the middle region of the lungs, near a main airway, and are associated to a history of smoking (bronchus)

Large cell carcinoma, also known as undifferentiated carcinoma, can develop in any area of the lungs. It has a tendency to spread and grow quickly, making treatment more difficult. Large cell neuroendocrine carcinoma, a subtype of huge cell carcinoma, may be a fast-growing malignancy that’s remarkably almost like small cell carcinoma.

Other subtypes: Adenosquamous carcinoma and sarcomatoid carcinoma are two other NSCLC subtypes that are far less common.


SCLC is a type of lung cancer that accounts for 10% to 15% of all lung malignancies and is also known as oat cell cancer.
This kind of lung cancer grows and spreads more quickly than NSCLC. At the time of diagnosis, almost 70% of those with SCLC will have cancer that has already spread.

Chemotherapy and radiation therapy work well for this cancer because it grows quickly. Unfortunately, the cancer will return for the majority of patients at some point.